Cartesian Therapeutics, Inc. RNAC
6.35 USD -0.01 (-0.08%)
Regular-session close
6.35 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
6.16 Day range 6.40
5.60 52-week range 11.00
- YTD
- -11.93%
- 1 year
- -12.17%
News
zacks.com Wall Street Analysts See a 379.63% Upside in Cartesian Therapeutics, Inc. (RNAC): Can the Stock Really Move This High? The consensus price target hints at a 379.6% upside potential for Cartesian Therapeutics, Inc. (RNAC). While empirical research shows that this sought-after metric is hardly effective, an upward…benzinga.com Cartesian Therapeutics Q3 EPS $(0.38) Beats $(0.95) Estimate Cartesian Therapeutics (NASDAQ:RNAC) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.95) by 60 percent. This is a 72.46 percent increase over losses of…
